The effects of mutational processes and selection on driver mutations across cancer types

The effects of mutational processes and selection on driver mutations across cancer types

Epidemiological evidence has long associated environmental mutagens with increased cancer risk. However, links between specific mutation-causing processes and the acquisition of individual driver mutations have remained obscure. Here we have used public cancer sequencing data from 11,336 cancers of...

Descripció completa

Dades bibliogràfiques
Autors principals:	Temko, D, Tomlinson, I, Severini, S, Schuster-Boeckler, P, Graham, T
Format:	Journal article
Publicat:	Springer Nature 2018

Ítems similars

The effects of mutational processes and selection on driver mutations across cancer types
per: Daniel Temko, et al.
Publicat: (2018-05-01)

Author Correction: The effects of mutational processes and selection on driver mutations across cancer types
per: Daniel Temko, et al.
Publicat: (2020-04-01)

Mutational landscape of cancer-driver genes across human cancers
per: Musalula Sinkala
Publicat: (2023-08-01)

Finding driver mutations in cancer: Elucidating the role of background mutational processes.
per: Anna-Leigh Brown, et al.
Publicat: (2019-04-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency
per: Schuster-Boeckler, P, et al.
Publicat: (2016)

An analysis of mutational signatures of synonymous mutations across 15 cancer types
per: Yannan Bin, et al.
Publicat: (2019-12-01)

Mutational signature distribution varies with DNA replication timing and strand asymmetry
per: Tomkova, M, et al.
Publicat: (2018)

Significant associations between driver gene mutations and DNA methylation alterations across many cancer types.
per: Yun-Ching Chen, et al.
Publicat: (2017-11-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
per: Tomkova, M, et al.
Publicat: (2016)

SDH mutations in cancer.
per: Bardella, C, et al.
Publicat: (2011)

SDH mutations in cancer
per: Bardella, C, et al.
Publicat: (2011)

Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
per: Runjun D. Kumar, et al.
Publicat: (2017-07-01)

5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA
per: Marketa Tomkova, et al.
Publicat: (2016-05-01)

Mutations, evolutionary theory and cancer.
per: Tomlinson, I
Publicat: (1993)

Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog.
per: Tomlinson, I, et al.
Publicat: (1999)

Tissue-Predisposition to Cancer Driver Mutations
per: Luriano Peters, et al.
Publicat: (2024-01-01)

Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs
per: Ng, AS, et al.
Publicat: (2023)

Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
per: Rebecca C Poulos, et al.
Publicat: (2018-11-01)

The mutation rate and cancer.
per: Tomlinson, I, et al.
Publicat: (1996)

Multiomics analysis of tumor mutational burden across cancer types
per: Lin Li, et al.
Publicat: (2021-01-01)

Tug-of-war between driver and passenger mutations in cancer and other adaptive processes
per: McFarland, Christopher D., et al.
Publicat: (2015)

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neo-antigen burden and immune response
per: Temko, D, et al.
Publicat: (2018)

How many mutations in a cancer?
per: Tomlinson, I, et al.
Publicat: (2002)

Mutation profiling of cancer drivers in Brazilian colorectal cancer
per: Wellington dos Santos, et al.
Publicat: (2019-09-01)

Replicative DNA polymerase mutations in cancer.
per: Heitzer, E, et al.
Publicat: (2014)

Replicative DNA polymerase mutations in cancer
per: Heitzer, E, et al.
Publicat: (2014)

Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
per: Michael B. Mumphrey, et al.
Publicat: (2023-08-01)

Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions
per: John K. L. Wong, et al.
Publicat: (2022-01-01)

Tissue, cell and stage specificity of (epi)mutations in cancers.
per: Sieber, O, et al.
Publicat: (2005)

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
per: Koushik Mondal, et al.
Publicat: (2024-07-01)

Driver Mutations in Lung Cancer—Mapping the Way Forward
per: Arun Chandrasekharan
Publicat: (2022-07-01)

Cis-regulatory mutations with driver hallmarks in major cancers
per: Zhongshan Cheng, et al.
Publicat: (2021-03-01)

Advances on Driver Mutations of Small Cell Lung Cancer
per: Bing TONG, et al.
Publicat: (2016-04-01)

An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.
per: Jasmine Foo, et al.
Publicat: (2015-09-01)

Mutations in Cancer Driver Genes: An Insight into Prostate Cancer Progression
per: Sahdeo, et al.
Publicat: (2019-09-01)

Identification of Single Nucleotide Non-coding Driver Mutations in Cancer
per: Kok A. Gan, et al.
Publicat: (2018-02-01)

CDMPred: a tool for predicting cancer driver missense mutations with high-quality passenger mutations
per: Lihua Wang, et al.
Publicat: (2024-09-01)

Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
per: Ming-Jun Shi, et al.
Publicat: (2020-09-01)

Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles.
per: Houriiyah Tegally, et al.
Publicat: (2020-01-01)

Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden
per: Jan Budczies, et al.
Publicat: (2018-12-01)